Maximize Your Impact At Handelsblatt Pharma 2026
Handelsblatt Pharma 2026, set for February 10, 2026, at Pullman Berlin Schweizerhof in Berlin, is one of the most influential strategy forums for senior decision-makers across the pharmaceutical and life sciences industries. Known for assembling C-level executives, regulatory authorities, investment partners, and digital health specialists, this event plays a key role in shaping commercial models, partnerships, and innovation pipelines in European pharma.
Attendees are there to evaluate clinical development strategies, digital transformation initiatives, and health policy shifts impacting drug pricing and market access. This is where long-term commercial plans are discussed, new supplier relationships initiate, and top-tier biotech collaborations emerge. With the enriched attendee list from Vendelux, sales and marketing teams gain early insight into which strategic buyers and innovation leaders are attending—allowing you to prioritize outreach based on their therapeutic focus areas, project timelines, and company mandates.
How Sales, Marketing And Revops Teams Can Use This Attendee List
Pharma events like Handelsblatt demand thoughtful, informed outreach that speaks directly to budget owners and R&D stakeholders. With Vendelux’s enriched conference attendee list, you can identify who’s driving innovation, procurement, and licensing discussions inside each organization. Use the attendee data to categorize contacts based on whether they’re from large pharma, mid-size biotechs, or patient-focused health tech firms.
Structure your outreach by segmenting decision-makers in areas like clinical operations, digital therapeutics, partnerships, or regulatory strategy. Teams looking to get more meetings can book time with clinical innovation leads or business development executives ahead of the event. Post-event, follow up with insights related to panel topics or shared therapeutic interests discussed onsite. Having this level of detail in your hands before arriving in Berlin ensures you make each conversation count, turning on-site engagement into qualified conversations and future revenue.
Timing Is Everything
Handelsblatt Pharma 2026 is happening on February 10, 2026. With just one full day of event time, it’s crucial that your team begins initiating contact months ahead to secure time with priority attendees. Use Vendelux’s data to identify who from your target accounts is expected to attend and align your messaging with their focus areas well in advance.
By starting in late 2025, you’ll enter the event with meetings already on the calendar and leave with a clearer pipeline of follow-ups. Getting ahead of the crowd is the difference between generic booth traffic and purposeful executive engagement.
What’s Included In The Handelsblatt Pharma 2026 Attendee List?
Vendelux provides visibility into the senior professionals expected to attend Handelsblatt Pharma 2026 through a combination of organizer data and proprietary predictive models. Clients can upload their list of target accounts to instantly find account matches within the attendee list.
The enriched attendee list includes first and last name, job title, company name, company website, location including city, state, and country, LinkedIn profile, verified email addresses, and phone numbers where available.
Where Is Handelsblatt Pharma 2026?
The event will be held at Pullman Berlin Schweizerhof in Berlin, Germany.
When Is Handelsblatt Pharma 2026?
Handelsblatt Pharma 2026 is scheduled for February 10, 2026.
What Type Of Event Is Handelsblatt Pharma 2026?
Handelsblatt Pharma 2026 is a one-day business conference focused on leadership insights and strategy within the pharmaceutical sector. The agenda typically features presentations from pharma executives, regulators, and technology providers, along with expert panels and networking sessions that support cross-sector collaboration.
How Many People Attend Handelsblatt Pharma 2026?
Handelsblatt Pharma regularly draws between 200 and 300 senior-level attendees from across Europe, including executives from pharmaceutical companies, digital health platforms, policymakers, and healthcare investors. Most attendees hold director-level titles and above, with a strong concentration of business unit heads and innovation leads.
